Matches in Wikidata for { <http://www.wikidata.org/entity/Q75842094> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q75842094 description "artículu científicu espublizáu en xunu de 2015" @default.
- Q75842094 description "im Juni 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q75842094 description "scientific article published on 01 June 2015" @default.
- Q75842094 description "wetenschappelijk artikel" @default.
- Q75842094 description "наукова стаття, опублікована в червні 2015" @default.
- Q75842094 name "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 name "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 type Item @default.
- Q75842094 label "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 label "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 prefLabel "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 prefLabel "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 P1433 Q75842094-753DF6CD-003A-4603-AFC3-A5E4B3829A33 @default.
- Q75842094 P1476 Q75842094-A7645F51-F525-4A41-AB6D-3BAF9A813CD8 @default.
- Q75842094 P2093 Q75842094-015B8805-AF97-4840-AD9B-499902990212 @default.
- Q75842094 P2093 Q75842094-042AE500-CEDD-41FA-AAD5-8C0F93B20109 @default.
- Q75842094 P2093 Q75842094-32CAF6DE-1B71-4ADE-BB38-5B49D07549CF @default.
- Q75842094 P2093 Q75842094-6E0721F5-B1D2-466A-961C-42E4C307E60D @default.
- Q75842094 P2093 Q75842094-7696454A-EE19-44FF-8A78-5EB8633F1A7F @default.
- Q75842094 P2093 Q75842094-8487216F-A81D-4888-952E-5FBBAD08473A @default.
- Q75842094 P2093 Q75842094-917A6ADF-3119-475A-B0A6-31ACC667CA28 @default.
- Q75842094 P2093 Q75842094-ACA33BA0-5CD3-4801-AC10-F0F3ADFF6C63 @default.
- Q75842094 P2093 Q75842094-F608FB06-0D8B-4475-BC7A-DB139866CDAC @default.
- Q75842094 P304 Q75842094-43E687B5-9436-4FB2-8B50-0E522A92013D @default.
- Q75842094 P31 Q75842094-075AEBC8-F35C-4345-B649-AA3E880025B7 @default.
- Q75842094 P356 Q75842094-47F21966-C825-45EF-9446-FA2BE7B4F7E1 @default.
- Q75842094 P433 Q75842094-28ED899C-A828-4105-AE78-B29077BD2C04 @default.
- Q75842094 P478 Q75842094-E32911B7-04EF-4F1A-B9C7-7801A7F00D4C @default.
- Q75842094 P50 Q75842094-09D2E3DB-1B43-4F57-9B3A-29BAFF0684B1 @default.
- Q75842094 P50 Q75842094-26516CFF-BB58-49BE-A8E4-ABE140D77704 @default.
- Q75842094 P50 Q75842094-D2273013-3BE8-4E90-807B-C8E78DD60D4E @default.
- Q75842094 P577 Q75842094-69CAAC3A-1531-4689-BD87-26781CA99618 @default.
- Q75842094 P698 Q75842094-A3F80AB2-D571-45F7-9528-E96A03ACC73B @default.
- Q75842094 P921 Q75842094-EAEEFB95-B642-47FA-A9A1-6D4C5DA2400B @default.
- Q75842094 P356 MPG.0000000000000713 @default.
- Q75842094 P698 26000887 @default.
- Q75842094 P1433 Q6295721 @default.
- Q75842094 P1476 "Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease" @default.
- Q75842094 P2093 "Anne Jacob" @default.
- Q75842094 P2093 "Claire Spyckerelle" @default.
- Q75842094 P2093 "Corinne Gower-Rousseau" @default.
- Q75842094 P2093 "EPIMAD Group" @default.
- Q75842094 P2093 "Guillaume Savoye" @default.
- Q75842094 P2093 "Hélène Sarter" @default.
- Q75842094 P2093 "Jean-Frédéric Colombel" @default.
- Q75842094 P2093 "Mathurin Fumery" @default.
- Q75842094 P2093 "Olivier Mouterde" @default.
- Q75842094 P304 "744-748" @default.
- Q75842094 P31 Q13442814 @default.
- Q75842094 P356 "10.1097/MPG.0000000000000713" @default.
- Q75842094 P433 "6" @default.
- Q75842094 P478 "60" @default.
- Q75842094 P50 Q30248039 @default.
- Q75842094 P50 Q56924796 @default.
- Q75842094 P50 Q57562063 @default.
- Q75842094 P577 "2015-06-01T00:00:00Z" @default.
- Q75842094 P698 "26000887" @default.
- Q75842094 P921 Q348260 @default.